Lomb Alaway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Company Continues to Make Progress on Planned Separation of Eye Health Business
Announces Leadership Team of Bausch + Lomb
Now Operates in Five Reportable Segments
Reaffirmed 2021 Full-Year Revenue and Adjusted EBITDA (non-GAAP)
Guidance Ranges
Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health or the Company or we ) today announced its first-quarter 2021 financial results.
Bausch Health entered 2021 with strong momentum as our recovery from the COVID-19 pandemic continues. Our business is generating strong cash flow, many of our leading products have increased market share in key markets, and we are advancing our pipeline, said Joseph C. Papa, chairman and CEO, Bausch Health. ....

United States , South Korea , Lainie Keller , Bausch Pharma , Josephc Papa , Arthur Shannon , Sam Eldessouky , Novaliq Gmb , Pauls Herendeen , Lomb Alaway , Revenue Service , Bausch Health Companies Inc , Bausch Health Company , Leadership Team Of Bausch , Canada Revenue Agency , Exchange Commission , International Rx , Bausch Health Companies , Amoun Pharmaceutical Company , Company Board , International Rx Segment , Bausch Health , Make Progress , Planned Separation , Eye Health , Leadership Team ,